Skip to main content
Year archive

PreveCeutical Medical — 2022 filings

All 31 regulatory filings released by PreveCeutical Medical (PREV) in 2022, sourced directly from the official regulator.

31 Filings
2022 Period
2022 filings (31)
Filing Released Lang
Interim MD&A - English.pdf
Interim / Quarterly Report 9M 2022
2022-11-25 English
52-109F2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2022-11-25 English
52-109F2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2022-11-25 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report 9M 2022
2022-11-25 English
News release - English.pdf
Regulatory Filings
2022-11-21 English
News release - English.pdf
Capital/Financing Update
2022-11-12 English
News release - English.pdf
Notice of Dividend Amount
2022-10-20 English
News release - English.pdf
Board/Management Information
2022-10-20 English
News release - English.pdf
Board/Management Information
2022-09-17 English
News release - English.pdf
Board/Management Information
2022-09-06 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2022-08-25 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings
2022-08-25 English
Interim MD&A - English.pdf
Regulatory Filings
2022-08-25 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report H1 2022
2022-08-25 English
News release - English.pdf
Capital/Financing Update
2022-07-22 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2022-05-31 English
Interim MD&A - English.pdf
Regulatory Filings
2022-05-31 English
Interim financial statements/report – English.pdf
Regulatory Filings
2022-05-31 English
News release - English.pdf
Regulatory Filings
2022-05-27 English
News release - English.pdf
Regulatory Filings
2022-05-09 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings
2022-05-03 English
Annual MD&A - English.pdf
Regulatory Filings
2022-05-03 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings
2022-05-03 English
Material change report - English.pdf
Regulatory Filings
2022-04-08 English
Certificate re dissemination to shareholders.pdf
Proxy Solicitation & Information Statement
2022-04-08 English
Other.pdf
Interim / Quarterly Report Q2 2022
2022-04-07 English
Notice of meeting - English.pdf
AGM Information
2022-04-07 English
Management information circular - English.PDF
Proxy Solicitation & Information Statement
2022-04-07 English
News release - English.pdf
Capital/Financing Update
2022-03-31 English
Notice of the meeting and record date - English.pdf
AGM Information
2022-03-04 English
News release - English.pdf
Legal Proceedings Report
2022-01-13 English